1. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
   Li-Ming Gao et al, 2019, Am J Physiol Lung Cell Mol Physiol CrossRef
2. Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy
   Zhenru Xu et al, 2020, Appl Microbiol Biotechnol CrossRef
3. LIMD1 Increases the Sensitivity of Lung Adenocarcinoma Cells to Cisplatin via the GADD45α/p38 MAPK Signaling Pathway
   Xiaofei Zeng et al, 2020, Front. Oncol. CrossRef
4. Neuroprotective effect of 3,3’-Diindolylmethane against perinatal asphyxia involves inhibition of the AhR and NMDA signaling and hypermethylation of specific genes
   J Rzemieniec et al, 2020, Apoptosis CrossRef
5. Up-regulation of VANGL1 by IGF2BPs and miR-29b-3p attenuates the detrimental effect of irradiation on lung adenocarcinoma
   Chun-cheng Hao et al, 2020, J Exp Clin Cancer Res CrossRef
6. Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway
   Li-Mei Wu et al, 2021, Front. Cell Dev. Biol. CrossRef
7. Integrated Genomics Identifies miR-181/TFAM Pathway as a Critical Driver of Drug Resistance in Melanoma
   Anna Barbato et al, 2021, IJMS CrossRef
8. Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers
   Asal Jalal Abadi et al, 2021, Biomolecules CrossRef
9. Mechanisms of resistance to chemotherapy in non-small cell lung cancer
   Hye-Young Min et al, 2021, Arch. Pharm. Res. CrossRef
10. The Local Anesthetic Bupivacaine Inhibits the Progression of Non-Small Cell Lung Cancer by Inducing Autophagy Through Akt/mTOR Signaling
    Jian-Hua Gu et al, 2021, Front. Oncol. CrossRef
11. MicroRNAs: The Link between the Metabolic Syndrome and Oncogenesis.
    Adriana Fodor et al, 2021, Int J Mol Sci CrossRef
12. miR-19b-3p relieves intervertebral disc degeneration through modulating PTEN/PI3K/Akt/mTOR signaling pathway
    Yulin Zhao et al, 2021, Aging CrossRef
13. Autophagy Regulation by Crosstalk between miRNAs and Ubiquitination System
    Junyan Qu et al, 2021, IJMS CrossRef
14. The MicroRNA-Based Strategies to Combat Cancer Chemoresistance via Regulating Autophagy
    Yuhe Lei et al, 2022, Front. Oncol. CrossRef
15. Is Autophagy Always a Barrier to Cisplatin Therapy?
    Jingwen Xu et al, 2022, Biomolecules CrossRef
16. MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin
    Maria Konoshenko et al, 2022, IJMS CrossRef
17. An autophagy-associated lncRNAs model for predicting the survival in non-small cell lung cancer patients
    Jing Hu et al, 2022, Front. Genet. CrossRef
18. The miR-181 family regulates colonic inflammation through its activity in the intestinal epithelium
    Monica T. Jimenez et al, 2022 CrossRef
19. Emerging role of non-coding RNAs in resistance to platinum-based anti-cancer agents in lung cancer
    Priya Mondal et al, 2023, Front. Pharmacol. CrossRef
20. PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells
    ZAHRA NASRPOUR NAVAEI et al, 2021 CrossRef
21. Analysis of Key Genes and miRNA-mRNA Networks Associated with Glucocorticoids Treatment in Chronic Obstructive Pulmonary Disease
    Jian-Jun Wu et al, 2024, COPD CrossRef
22. A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers
    Anna Barbato et al, 2024, Clin Exp Med CrossRef